UiPath grew like a weed after its public debut. But its growth could cool off as more competitors enter the market. It’s too early to assume it can expand and evolve into the next Salesforce. The ...
UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results